These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 15035448)

  • 1. [New TBE vaccine formulations--free of proteineous stabilizer and preservatives. Overview of clinical studies and first year post-marketing experience].
    Zent O; Wittermann Ch; Banzhoff A; Plentz A; Jilg W
    MMW Fortschr Med; 2004 Jan; 146(3-4):43. PubMed ID: 15035448
    [No Abstract]   [Full Text] [Related]  

  • 2. Long-term persistence of tick-borne encephalitis antibodies in children 5 years after first booster vaccination with Encepur Children.
    Wittermann C; Petri E; Zent O
    Vaccine; 2009 Mar; 27(10):1585-8. PubMed ID: 19162115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances in vaccination against tick-borne encephalitis.
    Rendi-Wagner P
    Expert Rev Vaccines; 2008 Jul; 7(5):589-96. PubMed ID: 18564014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of tick-borne encephalitis by FSME-IMMUN vaccines: review of a clinical development programme.
    Loew-Baselli A; Poellabauer EM; Pavlova BG; Fritsch S; Firth C; Petermann R; Barrett PN; Ehrlich HJ
    Vaccine; 2011 Oct; 29(43):7307-19. PubMed ID: 21843576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [New gelatine-free TBE vaccines with improved safety profile].
    Nagel G; Hennig R; Bröker M
    Klin Padiatr; 2006; 218(6):379; discussion 379. PubMed ID: 17080341
    [No Abstract]   [Full Text] [Related]  

  • 6. [Early tick-borne meningoencephalitis infections occur already in March. Pediatric vaccine is available again].
    MMW Fortschr Med; 2002 Mar; 144(11):58. PubMed ID: 12066518
    [No Abstract]   [Full Text] [Related]  

  • 7. Field effectiveness of vaccination against tick-borne encephalitis.
    Heinz FX; Holzmann H; Essl A; Kundi M
    Vaccine; 2007 Oct; 25(43):7559-67. PubMed ID: 17869389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [After vaccination for tick-borne encephalitis must onset of neurologic disorders be expected?].
    Hofmann H
    Wien Klin Wochenschr; 1995; 107(17):509-15. PubMed ID: 7483633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody response following administration of two paediatric tick-borne encephalitis vaccines using two different vaccination schedules.
    Wittermann C; Schöndorf I; Gniel D
    Vaccine; 2009 Mar; 27(10):1661-6. PubMed ID: 18940221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delayed humoral immunity in a patient with severe tick-borne encephalitis after complete active vaccination.
    Kleiter I; Jilg W; Bogdahn U; Steinbrecher A
    Infection; 2007 Feb; 35(1):26-9. PubMed ID: 17297586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tick-borne encephalitis (TBE) vaccination: applying the most suitable vaccination schedule.
    Schöndorf I; Beran J; Cizkova D; Lesna V; Banzhoff A; Zent O
    Vaccine; 2007 Feb; 25(8):1470-5. PubMed ID: 17196713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety, immunogenicity and tolerability of a new pediatric tick-borne encephalitis (TBE) vaccine, free of protein-derived stabilizer.
    Zent O; Banzhoff A; Hilbert AK; Meriste S; Słuzewski W; Wittermann Ch
    Vaccine; 2003 Sep; 21(25-26):3584-92. PubMed ID: 12922086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Post-marketing surveillance of immediate allergic reactions: polygeline-based versus polygeline-free pediatric TBE vaccine.
    Zent O; Hennig R
    Vaccine; 2004 Dec; 23(5):579-84. PubMed ID: 15542177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccination against tick-borne encephalitis--distant evaluation.
    Bobrowska E; Grzeszczuk A; Prokopowicz D
    Rocz Akad Med Bialymst; 1996; 41(1):44-50. PubMed ID: 8673804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Early summer meningoencephalitis vaccination, a preventive medicine measure with high acceptance in Austria].
    Kunz C; Hofmann H; Dippe H
    Wien Med Wochenschr; 1991; 141(12):273-6. PubMed ID: 1949821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Persistence of protective immunity following vaccination against tick-borne encephalitis--longer than expected?
    Rendi-Wagner P; Kundi M; Zent O; Dvorak G; Jaehnig P; Holzmann H; Mikolasek A; Kollaritsch H
    Vaccine; 2004 Jul; 22(21-22):2743-9. PubMed ID: 15246606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TBE booster immunization according to the rapid immunization schedule: are 3-year booster intervals really necessary?
    Zent O; Plentz A; Schwarz TF; Frühwein N; Kuhr HB; Broeker M; Banzhoff A; Jilg W
    Vaccine; 2004 Dec; 23(3):312-5. PubMed ID: 15530673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High burden of tick-borne encephalitis in Slovenia--challenge for vaccination policy.
    Grgič-Vitek M; Klavs I
    Vaccine; 2011 Jul; 29(32):5178-83. PubMed ID: 21620916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Dynamics of antibody formation after vaccination against tick-borne encephalitis].
    Pazdiora P; Januska J
    Epidemiol Mikrobiol Imunol; 2004 Feb; 53(1):17-21. PubMed ID: 15052830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tick-borne encephalitis vaccines: past and present.
    Zent O; Bröker M
    Expert Rev Vaccines; 2005 Oct; 4(5):747-55. PubMed ID: 16221075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.